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Ablation of the BPAG1 gene results in the dystonia musculorum mouse, exhibiting rapid spinal nerve degeneration,
dystonic movements, and severe ataxia. By de®ning the developmental and tissue-speci®c expression of the neuronal form
of BPAG1 (BPAG1-n) and by comparing the corresponding pathology in BPAG1 null mice, we seek here to understand
how absence of BPAG1 results in this devastating phenotype in mice and in potentially related human neurological
disorders. Throughout normal development, BPAG1-n was expressed in a variety of sensory and autonomic neuronal
structures, but was absent or reduced in areas such as basal ganglia that are often affected in dystonias and ataxias.
Interestingly, BPAG1-n was also expressed broadly in embryonic motor neurons, but expression declined dramatically after
birth. Despite these complex developmental patterns, BPAG10/0 pathology was restricted largely to postnatal develop-
ment. Moreover, gross neuronal degeneration was restricted to only a few regions where BPAG1-n was found, including
dorsal root ganglion neurons and a small subset of motor neurons. Most notably, while skeletal muscle was normal,
appearance of severe dystonic ataxia correlated with postnatal degeneration of muscle spindles. Collectively, our ®ndings
suggest a mechanism for the BPAG1 null phenotype and indicate that different neurons respond differently to the absence
of BPAG1-n, a cytoskeletal linker protein. q 1997 Academic Press
INTRODUCTION The dystonia musculorum (dt) mouse is a very interesting
neurological mutant, ®rst discovered as a spontaneously oc-
curring, autosomal recessive variant (Duchen et al., 1963).Genetically derived or experimentally induced neurologi-
Mice affected with dt are seemingly normal at birth, but bycal diseases in mice can provide excellent models in the
10±12 days they begin twitching, writhing, and exhibitingquest to understand and treat human disorders of the ner-
uncoordinated movements. These abnormal motions are ac-vous system. They can be utilized to gain knowledge of the
companied by spasms and by bizarre ¯exions, pronations,pathogenic course of the modeled disease, allow a thorough
and posturings of the limbs, thereby yielding the classi®ca-molecular and biochemical examination well beyond the
tion of dystonia for these animals. We and others have notedrange of patient analysis, and even lead to the discovery
in phenotypic (10 days and older) dt/dt mice severe degener-of the genetic basis for a related human disease. Several
ation in the axons of primary sensory neurons, especiallyexamples, including the impressive work with amyotrophic
those of the spinal dorsal root ganglia (Guo et al., 1995;lateral sclerosis (ALS) in mice (see review by Brown, 1995),
Duchen and Strich, 1964; Janota, 1972; Duchen, 1976; So-underscore the importance of these models.
telo and Guenet, 1988; Kothary et al., 1988; Al-Ali and Al-
Zuhair, 1989). These defects appear to be the result of a
primary defect in the neurons themselves: chimeric mice1 To whom correspondence should be addressed at Department
composed of dt/dt and wild-type cells exhibit axonal swell-of Molecular Genetics and Cell Biology, Howard Hughes Medical
ings only in the (tagged) dt/dt neurons (Campbell and Pe-Institute, 5841 S. Maryland Ave., Rm. N314, Chicago, IL 60637.
Fax: 773-702-0141. terson, 1992). Surprisingly, despite the dystonic movements
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and the rapidity of degeneration in juvenile dt/dt animals, MATERIALS AND METHODS
no consistent pathology has been detected either in motor
neurons or in skeletal muscle except in late stages of the In Situ Hybridization
degenerative process (Duchen, 1976). Given that exclusively
In situ hybridization was performed as previously describedsensory neurologic degeneration in humans is usually late
(Yang et al., 1996). Brie¯y, tissues were frozen in OCT (Miles, Inc.,in onset and signi®cantly milder in appearance, the known
Elkhart, IN) over supercooled isopentane, cut at 15 mm on a cryo-pathology of dt does not adequately explain the dramatic
stat, collected on Superfrost Plus slides (Fischer), and allowed todecline in locomotive ability observed in these mice.
dry for 1 hr. Slides were next ®xed in 4% paraformaldehyde, washedAn important prerequisite to understanding the patho-
in phosphate-buffered saline, pH 7.4 (PBS), acetylated with acetic
genesis of dt is to elucidate the genetic basis of the disorder. anhydride, washed again, and put into prehybridization solution for
Recently, we inadvertently generated the dt phenotype by up to 12 hr. This solution was replaced with hybridization solution
gene targeting of the BPAG1 gene, originally thought to be containing a digoxigenin (DIG)-labeled cRNA probe (400 ng/ml),
expressed exclusively in strati®ed epithelia. Matings re- corresponding to the amino-terminal coding sequence of the
BPAG1-n mRNA, and slides were incubated in a humidi®ed cham-vealed BPAG1 to be allelic with the dt locus, though only
ber at 727C for 10 hr. Stringency washes were then performed atsome strains of dt/dt mice lacked the BPAG1 protein in the
727C in 0.21 SSC (sodium chloride/sodium citrate) for 2 hr. Finally,epidermis (Guo et al., 1995). That the BPAG1 gene underlies
the slides were incubated in antibody block (10% normal goat se-dt was substantiated by Brown et al. (1995), who used classi-
rum) for 1 hr, placed in the anti-DIG antibody (1:5000; Boehringer-
cal genetics to map and clone the dt locus. Both groups Mannheim, Indianapolis, IN) overnight at 47C, and reacted using
subsequently identi®ed a novel splice form of BPAG1 ex- an NBT/BCIP detection solution. Sense and antisense cRNA probes
pressed in neurons (BPAG1-n). We have demonstrated that were generated by in vitro transcription of Isl-1 or BPAG1-n parent
this 280-kDa neuronal form is a cytoskeletal linker protein plasmids, yielding 1.5- and 1.2-kb transcripts, respectively. Probes
were puri®ed using Sephadex spin columns (Boehringer-Mann-with the capacity to bind neuro®laments and actin ®la-
heim).ments (Yang et al., 1996).
A number of questions still remain. Foremost is whether
there is a human equivalent of dt with mutations in the
ImmunohistochemistryBPAG1 gene. Thus far, no neurologic diseases with symp-
toms matching the severe sensory ataxia of the BPAG1 Immunohistochemistry with the antibody to BPAG1-n was per-
knockout animals are known which map to the BPAG1 formed using the Vector ABC-AP kit (Vector Laboratories, Burlin-
gene locus on chromosome 6p12 (Brown et al., 1994). The game, CA). Tissue was processed and sectioned as with in situ
uncovering of a human disease equivalent for dt rests upon hybridization, but after drying sections were placed for 20 min at
0207C and then ®xed for 10 min in 0207C methanol. After briefa detailed knowledge of the pathology of the BPAG1 null
washes in Tris-buffered saline, pH 7.4 (TBS), sections were thenand/or dt phenotype. At present, the description of this dis-
blocked for 1 hr in 3% BSA, 1% glycine, 10% NGS, and 0.4%order as one involving purely sensory degeneration stands
Triton in TBS (see Jones et al., 1993). Anti-BPAG1-n (Yang et al.,at odds with the known ataxic, dystonic movements of the
1996) was diluted in blocking solution at 1:25 and added to the
mutant animals. Ataxia is often associated with defects in slides overnight at room temperature. Sections were then washed
the cerebellum, as vividly illustrated by the profound loss in TBS, incubated in biotinylated goat anti-rabbit for 1 hr (1:200;
of cerebellar Purkinje cells in human spinocerebellar ataxia Vector Laboratories), washed again, and then placed in the ABC-
type I (Servadio et al., 1995). On the other hand, dystonia AP reagent for 1 hr. Samples were detected using the NBT/BCIP
solution described above. Immunogold labeling was performed us-is almost invariably linked to alterations in basal ganglia
ing Amersham reagents (Arlington Heights, IL) following the proto-(Markham, 1992). Signi®cantly, alterations in either cere-
col of Yang et al. (1996).bellum and/or basal ganglia are not a consistent feature of
Immunohistochemistry of the neuro®lament H protein (NF-H)the pathology of dt, leaving open the issue of the defect(s)
was accomplished using a monoclonal primary antibody at 1:1000responsible for the voluntary, spastic motions. The resolu-
(SMI31, Sternberger Monoclonals, Baltimore, MD) and a goat anti-
tion of this issue bears upon the larger question of a human rat FITC secondary (1:100, Cappel), following the protocol de-
disease equivalent. Until the precise changes that cause dt scribed in Yang et al. (1996).
are determined, it will be dif®cult to search meaningfully
for possible candidate disorders.
In this report, we analyze BPAG1-n mRNA and protein Tissue Processing for Pathology
expression in the developing and adult nervous system. In
BPAG1 knockout animals and littermates (as determined by in-light of our new ®ndings, we have reevaluated the histopa-
spection, immunohistochemistry, and/or Southern hybridization)thology of the BPAG1 null (dt) mice. Our results point to
were pericardially perfused with freshly made 4% paraformalde-a novel explanation for the spastic, dystonic movements of
hyde in PBS. Individual tissues were dissected out and post®xed
the mouse and enable us to generate a theoretical blueprint overnight at 47C in the perfusion solution, washed twice in PBS,
for understanding BPAG1-n's role in various neuronal cell and then processed either for paraf®n embedding or for electron
types and for predicting how a loss of BPAG1 in humans microscopy. Paraf®n sections were cut at 5 mm, rehydrated ac-
cording to Jones et al. (1993), and either stained with hematoxylinmight present itself.
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FIG. 1. BPAG1-n is expressed in Postnatal Day 3 sensory neurons. (A, B) In situ hybridization with a BPAG1-n cRNA probe (antisense,
A; sense, B) on frozen sections (15 mm) of the lumbar spinal cord (SC) of Postnatal Day 3 (PN3) wild-type mice. Note abundant RNA
localization to the cell bodies of the dorsal root ganglia neurons (DRG) and absence of detectable label in exiting Schwann cell-containing
nerve ®bers. (C) Immunohistochemistry on a lumbar spinal cord section serial to A using an antibody against the BPAG1-n actin binding
domain. Note strong labeling in the axons of the dorsal root ganglia neurons, including the spinal nerve (SN) and dorsal root (DR). Low
level labeling in the adjacent spinal cord represents background staining seen both when no primary antibody is used and in BPAG10/0
tissue. Bar represents 160 mm in A, B, and C.
and eosin or used for immunohistochemistry. Tissue for semithin with our earlier ®ndings, the RNA localized to the perikarya
sections was treated as previously described (Guo et al., 1995). of the neurons in the ganglia (Fig. 1A), while the protein
seemed to concentrate in the exiting dorsal root and spinal
nerve (Fig. 1C). The antibody labeling detected in the gangliaNorthern Blot Analysis
itself (Fig. 1C) was most likely due to staining of small axons
Total RNA was extracted from different aged embryos using the surrounding the perikarya, as revealed more clearly at higher
Trizol reagent and accompanying protocol (Gibco, Inc.). Northern magni®cation (data not shown). These data also illuminated
analysis of these RNAs was done using the instructions and re- an observation that held for all other tissues examined: anti-
agents for DIG-based nonradioactive hybridization from Boeh- BPAG1-n staining was present in the cells and tissues that
ringer-Mannheim. Probes were generated as described above; the were labeled by in situ hybridization with BPAG1-n cRNA.
GAPDH plasmid was obtained from Ambion, Inc. The detection In the present report, we therefore present RNA and protein
procedure utilized the CSPD reagent (Boehringer-Mannheim) and
localization results interchangeably.standard autoradiograph ®lm (Kodak).
Based upon BPAG1-n expression in the DRG, we won-
dered whether BPAG1-n expression might extend to other
sensory components in the nervous system. By exploringRESULTS
the postnatal localization, we discovered that BPAG1-n is,
in fact, a component of an array of neuronal structures sig-BPAG1-n Is Expressed in Many Primary Sensory
ni®cantly broader than ®rst anticipated from the histopa-Neurons
thology. These areas, most of which have some relationship
To identify the cells that express BPAG1-n, we used in to sensory function, are summarized below and in Table 1.
situ hybridization and immunohistochemistry on perinatal Expression appeared to be largely con®ned to the nervous
[17.5 days after conception (E17.5) up to 5 days after birth] system.
mouse tissues. As expected from preliminary studies on ju- BPAG1-n mRNA and protein were detected in the neu-
venile animals (Brown et al., 1995; Yang et al., 1996), both ronal derivatives of neural crest and placodes, including
BPAG1-n RNA and protein are highly expressed in the dorsal DRG (see Fig. 1), sympathetic ganglia (Fig. 2A), and ganglia
of the enteric nervous system (Fig. 2B). Interestingly,root ganglia (DRG) of 3-day-old animals (Fig. 1). Consistent
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TABLE 1
Summary of BPAG1-n Expression
Neuronal subtype Embryonic Postnatal Pathology?
Dorsal root ganglia ///// ///// Yes
Optic nerve (I) /// /// No
Olfactory nerve (II) /// /// No
Trigeminal ganglia and nuclei (V) ///// ///// Yes
Facioacoustic ganglia (VII) //// //// Yes
Vestibulocochlear ganglia and nuclei (VIII) //// //// No
Superior and inferior glossopharyngeal (IX) //// //// Yes
Superior and inferior ganglia of vagus (X) //// //// Yes
Sympathetic ganglia //// //// No
Enteric nervous system /// /// No
Pontine/olivary nuclei // // Yes
Motor neurons //// r / / Slight
Ventricular zone/¯oor plate /// r 00 00 nd
Basal ganglia 00 00 No
Cerebellum 00 00 r / No
BPAG1-n was not detected in other neural crest derivatives in older animals. This said, no signi®cant pathology has
been detected in the BPAG1 null cerebellum or in the dtsuch as Schwann cells (see Fig. 1A or Yang et al., 1996) or
cerebellum (Sotelo and Guenet, 1988), suggesting that Pur-melanocytes (data not shown).
kinge cells are able to survive in the absence of BPAG1-n,BPAG1-n appeared to be especially abundant in the cra-
in contrast to dorsal root ganglia. Finally, we did not detectnial nerves that control special and general sensation. Label-
BPAG1-n mRNA or protein in basal ganglia. These ®ndingsing in the special sense neurons included the optic and olfac-
were particularly relevant in light of the fact that basaltory nerves (I and II, respectively) and the vestibulocochlear
ganglia abnormalities are thought to be responsible for hu-nerve (VIII). Shown are examples of axons from the optic
man dystonias (Markham, 1992).nerve inside the retina (Fig. 2C) and of cell bodies in spiral
ganglia of the inner ear (Fig. 2D). Strong expression was also
BPAG10/0 Neuronal Pathology Is Limitedobserved in general sensory ganglia of the trigeminal nerve
The discovery of widespread expression of BPAG1-n in(V) (Fig. 2E) and in peripheral ganglia of the VIIth (facial),
sensory and autonomic neurons prompted us to examineIXth (glossopharyngial), and Xth (vagus) nerves (data not
BPAG1 null mice for alterations in these areas. Degenera-shown). We conclude that BPAG1-n is expressed postnatally
tion at the light microscopic level was seen in processesin most if not all neuronal components of placode and crest-
originating from DRG neurons, in pontine and olivary nu-derived cranial nerves involved with sensation.
clei, and in the Vth, VIIth, IXth, and Xth nerves. Conversely,
no changes were observed in cranial nerves I, II, and VIII;
this correlated well with the lack of outward signs of blind-BPAG1-n Is Expressed in Second-Order Sensory
ness and deafness. Also, the sympathetic and enteric neu-Neurons but Not in Basal Ganglia or in Early
rons, which are not involved in sensation, were histologi-Postnatal Cerebellar Neurons
cally normal, as were non-BPAG1-n-expressing neuronal
The highly speci®c localization of RNA and protein to areas like the basal ganglia. Taken together with lack of
primary sensory neurons of DRG and cranial nerves led us obvious cerebellar abnormalities, the pathology provided
to wonder whether BPAG1-n might also be expressed in support for the primacy of sensory neuronal degeneration
their second-order neuronal target cells. Interestingly, very in the BPAG1 null phenotype (see Table 1 for comparative
few central nervous system components labeled with summary), and it also matched with the known histopathol-
BPAG1-n cRNA or antibody. However, expression was de- ogy of the dt mouse (Duchen and Strich, 1964; Sotelo and
tected in some brain stem nuclei, especially the olivary and Guenet, 1988). However, it further revealed that some sen-
pontine nuclei (Fig. 2F). The BPAG1-n protein could also sory neurons that expressed BPAG1-n were not appreciably
be found in axons of these neurons that coursed to the cere- affected by its absence.
bellum (cerebrocerebellar tract), as well as primary sensory
BPAG1-n Is Expressed throughout Developmentaxons in the spinocerebellar tract, though no RNA was lo-
and Is Present in the Ventral Spinal Cordcalized to cerebellar neurons at early postnatal ages (data
not shown). We did, however, see speci®c anti-BPAG1-n While the expanded expression of postnatal BPAG1-n to
special sensory cranial nerves and autonomic nerves did notlabeling in the Purkinge layer of cells within the cerebellum
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FIG. 2. BPAG1-n is expressed in many postnatal sensory neuronal cell types. Tissues from Postnatal Day 3 wild-type mice were frozen,
sectioned (15 mm), and either hybridized with digoxigenin-labeled BPAG1-n cRNA (A, D, and E) or stained with anti-BPAG1-n antibodies
(B, C, and F). Shown are examples of BPAG1-n expression in (A) sympathetic ganglia (SG); (B) enteric ganglia (ENT) of the small intestine
(INT); (C) axons of the optic nerve (ON) in the axonal layer of the retina (Ret) [note background color in the pigmented epithelia of the
retina (Pig Ep)]; (D) spiral ganglia (Sp G) of the vestibulocochlear nerve; (E) trigeminal ganglia (TG); and (F) pontine nuclei (Pont). Bar
represents 160 mm in A, B, D, and E and 80 mm in C and F.
contribute to our understanding of the dramatic clinical pression was detected in all neurons which also displayed
BPAG1-n expression at birth. An example is the dorsal rootdefects in dt animals, it was intriguing. Even more unantici-
pated was the presence of BPAG1-n in early embryonic de- ganglia, where BPAG1-n was detected from E17.5 through
E9.5, the earliest day examined (Fig. 3). As deduced from invelopment. Two key ®ndings emerged from our analysis of
BPAG1-n expression in developing mouse embryos. situ hybridization, BPAG1-n was a consistent component
of postmitotic neurons in the DRG near or at the start ofFirst, throughout embryonic development, BPAG1-n ex-
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FIG. 3. BPAG1-n is present in sensory neurons throughout development. Wild-type embryos from the ages indicated were sectioned (15
mm) and hybridized with a BPAG1-n cRNA probe. Shown are sections of dorsal root ganglia at (A) E17.5; (B) E15.5; (C) E13.5; (D) E11.5;
(E) E10.5; and (F) E9.5 (dashes outline the ganglion). Bar represents 130 mm in A±D and 65 mm in E and F.
its development in the mouse. This was unexpected, given The BPAG1-n mRNA Is Unchanged in Size during
Developmentthat the dt phenotype is only overtly apparent at about 2
weeks after birth.
Given the striking and varied patterns of BPAG1-n expres-The second surprising ®nding was that BPAG1-n antibod-
sion during development, we wondered whether multipleies and cRNAs exhibited marked labeling in the ventral
BPAG1-n transcripts might exist to account for this. North-spinal cord during embryogenesis. Figure 4 illustrates
ern blot analysis on total RNA extracts of embryos of vari-BPAG1-n cRNA localization in the spinal cord from E9.5
ous ages revealed a single hybridizing band of 12 kb through-onward. At E9.5 and E10.5, BPAG1-n was detected through-
out development (Fig. 6). While we cannot rule out the pos-out the ventral portion of the neural tube, including the
sibility that minor differences might exist, this RNAarea corresponding to the ¯oor plate and the newly formed
corresponded to the size of the postnatal form(s) of BPAG1-mantle layer (see example in Figs. 4A and 4C). This hybrid-
n (Yang et al., 1996). The 9-kb BPAG1-e mRNA was notization was at least as intense as that in the dorsal root
detected with the 5* BPAG1-n cRNA probe, consistent withganglia (compare arrowhead and arrow, respectively, in Figs.
the fact that this sequence is not present in the BPAG1-e4A and 4C) and was faithfully mirrored by BPAG1-n anti-
mRNA (Brown et al., 1995; Yang et al., 1996).body labeling (data not shown). As the embryo aged,
BPAG1-n expression in the spinal cord became restricted to
the ventral horn, i.e., the site of developing motor neurons Mild but Distinct Motor Neuron Changes at Early
(Figs. 4C and 4E). Labeling with antisense cRNA of Isl-1, a Stages of Clinical Decline in BPAG1 Null Mice
marker for motor neurons (Pfaff et al., 1996), con®rmed the
identity of these hybridizing cells (Figs. 4B, 4D, and 4F). The prominent embryonic and persistent but weak post-
natal expression of BPAG1-n in some motor neurons led usFrom E17.5 onward, mRNA expression of BPAG1-n in the
spinal cord was greatly reduced: ¯oor plate staining was ab- to more closely examine BPAG10/0 mice for signs of early
motor degeneration. Soon after the ®rst signs of spasticsent and labeling in the motor neurons (MNs), as judged by
comparison with the adjacent dorsal root ganglia, was now ataxia in knockouts (Postnatal Day 13), axonal swellings
were detected both in the ventral root and in some ventralquite weak [Fig. 5A; compare arrowhead (MNs) versus arrow
(DRG)]. This said, some motor neuron labeling was clearly horn processes in the spinal cord of BPAG1 null mice (Figs.
7A and 7C), while no swellings were detected in either ven-apparent, as seen in sagittal section upon long exposure with
the color reagent (see Fig. 5B). Furthermore, prolonged anti- tral root or horn of age-matched wild-type animals (data
not shown). These swellings were much less frequent thanbody incubations with postnatal spinal cord revealed faint
but speci®c anti-BPAG1-n labeling in the ventral root, indica- those seen in the dorsal root (Fig. 7B). However, at the ultra-
structural level, the swollen axons of the ventral root weretive of persistent axonal expression in some postnatal motor
neurons (compare Fig. 5C with control, Fig. 5D). indistinguishable from their sensory counterparts, indicat-
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FIG. 5. BPAG1-n expression is reduced but weakly present in
postnatal motor neurons. (A, B) Reduction by E17.5 of BPAG1-n
cRNA antisense signal in the ventral horn compared with the dor-
sal root ganglia (A; arrowhead points to ventral horn and arrow to
dorsal root ganglia). As viewed in a much longer exposure of a
sagittal section (B), BPAG1-n hybridization to motor neurons is
clearly still apparent. (C, D) Immunogold histochemistry using pro-
longed antibody incubation (24 hr) and gold particle reaction (1
hr) with anti-BPAG1-n on postnatal Day 3 20-mm sections. Labeling
was detected in the ventral root (vr) [arrow in (C) compared to no
primary antibody control in (D)]. Bar represents 80 mm in A and B
and 33 mm in C and D.
ing most likely a similar etiology (data not shown). Most
notably, the swellings contained an array of disorganized
neuro®laments and abundant secondary lysosomes (see
Yang et al., 1996, for analogous sensory root swellings).
FIG. 4. BPAG1-n is expressed in embryonic motor neurons. (A±
Abnormalities in motor neurons were also uncovered usingF) In situ hybridization of serial sections with BPAG1-n (A, C, and
an antibody, SMI-31, to the hyperphosphorylated forms ofE) and Isl-1 (B, D, and F) cRNA probes. Ages are as indicated. Note
neuro®lament-H (NF-H). This antibody is known to yield athe precisely overlapping expression of the two probes in the ven-
discrete ®lament pattern in axons and no staining in neuraltral horn region of the spinal cord (indicated in A, C, and E with
cell bodies; however, in a variety of degenerative neurologicalan arrowhead), but disparate expression in the ventricular zone
disorders, the antibody stains neuronal perikarya (Cork et al.,(where BPAG1-n is found at E9.5 through E15.5) and in other re-
1988; Guiroy et al., 1989). Interestingly, the SMI-31 antibodygions of the spinal cord (where Isl-1 is found). Abbreviations: D,
showed staining in some cell bodies in the ventral horn ofdorsal; V, ventral; SC, spinal cord. Arrowheads point to the ventral
horn, while arrows point to the dorsal root ganglia. Bar represents BPAG1 null mice (Fig. 7D). These abnormalities, absent in
80 mm in A±D and 160 mm in E and F. the wild-type control (Fig. 7E), were signi®cantly more abun-
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neurons seen in the ventral horn and root track to the muscle
spindle as gamma motor neurons. Unfortunately, we could
not directly assess this possibility, given that no speci®c
markers for this subtype of neuron have yet been identi®ed.
Interestingly, muscle spindle ®bers displayed clear signs
of degeneration in the BPAG1-n null mouse (Fig. 8D, com-
pare with control in Fig. 8C; spindle marked by arrow).
While seemingly normal spindles could be found in the null
animals, the vast majority of spindles lacked obvious in-
nervation and showed signs of degeneration. In contrast,
extrafusal skeletal muscle was histologically normal (com-
pare Figs. 8C and 8D).
Only Sensory Neuron Pathology Is Prominent prior
to the Clinical Onset
To further understand the relationship between the dt
phenotype and the restricted histological changes we had
de®ned, we examined sensory neurons, motor neurons, and
muscle spindles in BPAG10/0 animals prior to overt signs
of ataxia. Pathology was apparent in the sensory neurons ofFIG. 6. An 12 kb BPAG1-n RNA band throughout in develop-
both 4- and 9-day-old mice (Fig. 9). Most notably, the largement. Northern blot of total RNA isolated from embryos of the
axonal swellings were abundant even in 4-day-old BPAG1indicated ages using BPAG1-n and GAPDH probes simultaneously.
Blot was exposed to ®lm for 30 min. Note the persistent single 12- 0/0 animals, i.e., a week before the ®rst signs of ataxia (Fig.
kb band (marked with an arrow and labeled as BPAG1-n) corre- 9A). Interestingly, these swellings were rarely surrounded
sponding to the BPAG1-n messages. STD, RNA size ladder. by noticeable myelin sheaths. Moreover, there appeared to
be far fewer myelinated ®bers in the dorsal root than ex-
pected for this age (compare knockout, Fig. 9B, to control,
Fig. 9C). The paucity of myelinated ®bers in the sensory
dant in the cell bodies of dorsal root ganglia of BPAG knock- roots of BPAG1 null animals was not observed in the motor
outs (Fig. 7G). In addition to the perikarya staining, axonal nerve root at any of the ages examined (data not shown).
staining was aberrant in both the ventral and dorsal roots Taken together with the absence of BPAG1-n staining in
(Figs. 7F and 7G, respectively). This staining was very intense Schwann cells, these ®ndings suggest that the sensory axo-
in what appeared to be axonal swellings (arrowheads in Figs. nal degeneration may result in inhibition of the myelination
7F and 7G), consistent with neuro®lament accumulations process which is taking place in early postnatal develop-
seen in these structures at the ultrastructural level (Yang et ment.
al., 1996; Janota, 1972; Al-Ali and Al-Zuhair, 1989). These In contrast to the marked early pathology in the sensory
intense aggregates of label were never detected in wild-type nervous system, motor neurons and muscle spindles ap-
ventral or dorsal roots (data not shown). peared normal in 4- and 9-day-old BPAG1 null animals.
While this ®nding could be a result of an inability to detect
changes in these areas (a small percentage of the total num-
Spindles, but Not Extrafusal Fibers, Degenerate in ber of spindles or motor neurons could have been abnormal,
the BPAG10/0 Mouse but not present in the sections examined), it does illuminate
a very interesting correlation between the onset of clinicalIn light of the de®nitive ventral root expression and pathol-
abnormalities and the observation of obvious signs of degen-ogy, skeletal muscle was examined for BPAG1-n nerve ®ber
eration in the muscle spindle and motor neurons. Further-expression. Extrafusal skeletal muscle was not labeled appre-
more, these results suggest that muscle spindle degenera-ciably with either BPAG1-n cRNA or antibody; on the other
tion is likely to be a secondary event caused by axonal de-hand, muscle spindles were prominently stained with anti-
generation and not an intrinsic developmental defect.body (Fig. 8). As illustrated in Fig. 8A, spindles are most
easily recognized by a nuclear bag region of intrafusal muscle
®bers surrounded by Ia afferent sensory nerves. These sen-
DISCUSSIONsory nerves labeled strongly with anti-BPAG1-n (Fig. 8B).
Outside of the nuclear bag area, intrafusal spindle ®bers are
BPAG1-n Is Expressed in Many Neurons but Onlyinnervated by both sensory (Ia and II afferent) and motor
a Few Exhibit Degeneration(gamma) neurons. Due to the lack of neuronal BPAG1-n
staining in the extrafusal ®bers, where most motor axons Our expression survey of postnatal mouse tissues uncov-
ered BPAG1-n in an unexpectedly large array of neuronalterminate, it is possible that the BPAG1-n-expressing motor
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FIG. 7. Histopathology of motor neurons in BPAG10/0 mice. Postnatal Day 13 (A±C) and Day 15 (E±G) BPAG1-n wild-type and 0/0
animals were pericardially perfused with 4% paraformaldehyde, and relevant neural tissues were removed and post®xed overnight in the 4%
paraformaldehyde. Tissues were then processed for ultrastructural analysis (A±C) or for paraf®n embedment (D±G). (A±C) Toludine blue stained,
semithin sections of the ventral (A) and dorsal (B) roots and the adjacent cervical spinal cord (C). A and B show degenerating axons (arrowheads)
of the ventral and dorsal root, respectively. Note that many more abnormal axons can be observed in the dorsal root. C depicts a swollen cellular
process in the region of the ventral horn (arrow). (D±G) Immuno¯uorescence on 7-mm paraf®n sections using an antibody to the hyperphosphory-
lated form of neuro®lament-H (SMI-31). SMI-31 immunoreactivity can be detected in the perikarya of motor neurons (D) and dorsal root ganglion
neurons (G) in BPAG1 null sections but not in sections from wild-type animals (ventral horn, E). Abnormal aggregations of SMI-31 staining are
apparent in the axons of the ventral (F) and dorsal (G) root (as marked by arrowheads). As observed with Toludine blue staining in A±C, much
more evidence of pathology detected with the SMI-31 antibody is observed in the dorsal root and dorsal root ganglion neurons. Wild-type BPAG1
dorsal and ventral roots showed no evidence of histological swellings or immunohistological neuro®lament abnormalities (data not shown). Bar
represents 30 mm in A, 26 mm in B, 20 mm in C, 35 mm in D, 35 mm in E, 50 mm in F, and 50 mm in G.
structures. This list extended well beyond our previous fo- Why might some neurons lacking BPAG1-n be healthy
while others exhibit rapid degeneration? This is a very dif®-cus on dorsal root ganglia neurons (Yang et al., 1996) known
to be important in dt pathology. We know now that BPAG1- cult question, since most neurons are classi®ed by function,
transmitter composition, or location, rather than by anyn is expressed in all primary somato- and mechanosensory
neurons, the cranial nerves governing the special senses, structural differences. A priori, it is possible that some neu-
rons express other proteins that enable them to compensateautonomic ganglia, and even some second-order sensory
structures. Notably absent from this list were basal ganglia for the loss of BPAG1-n. Alternatively, since we believe that
BPAG1-n is involved in providing mechanical support and/neurons, which now can be excluded from playing a primary
role in dt pathogenesis due to the lack of BPAG1-n expres- or cytoskeletal stabilization to neurons (Yang et al., 1996),
any differences in the requirement for these functions couldsion (see Table 1).
We were intrigued to ®nd that BPAG1-n was expressed account for the differential sensitivity of neurons to the loss
of BPAG1-n. For instance, the long sensory axons projectingin a wide variety of neuronal tissues that have not been
implicated in dt pathology. Interestingly, the autonomic to the limbs from the dorsal root ganglia are subject to a
great deal more mechanical stress than the axons of thenervous system, enteric nervous system, and the special
sensory neurons are areas that express BPAG1-n, but do not VIIIth nerve in the inner ear. Perhaps this added stress makes
the peripheral sensory axons especially dependent upon acontribute to the dt phenotype. Therefore, these cells seem
to function normally without BPAG1-n protein, at least well-stabilized, tethered cytoskeleton. One caveat to this
hypothesis is the fact that some brain stem nuclei (whichwithin the window of the null animal's lifetime.
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FIG. 8. Muscle spindle degeneration in the BPAG10/0 mice. (A) Schematic of the nuclear bag area of a muscle spindle, including
intrafusal (spindle) ®bers and a surrounding Ia afferent nerve. Nuclei in the nerve represent axon-ensheathing Schwann cells. (B) Immunohis-
tochemistry using anti-BPAG1-n antibodies on a 15-mm fresh frozen section of wild-type muscle. Prominent staining is seen surrounding
the muscle spindle, with relatively little label detected elsewhere in the muscle. (C, D) Postnatal Day 13 BPAG1 wild-type and 0/0 mice
were pericardially perfused with 4% paraformaldehyde and then processed for paraf®n sectioning. Paraf®n sections at 7 mm were stained
with hematoxylin and eosin. Comparison of wild type (C) versus knockout (D) reveals muscle spindle degeneration in the absence of
BPAG1-n; arrows point to the spindle in each case. Note the lack of detectable axons in the knockout spindle and prominent axonal
process (arrowhead in C) surrounding the spindle in the wild type. Note also that extrafusal ®bers in BPAG10/0muscle look histologically
normal (compare C and D). Bar represents 25 mm in B and 15 mm in C and D.
bellar and hippocampal neurons in older animals (Yang andare relatively small neurons) also undergo degeneration;
Fuchs, unpublished results). Regardless, we found no evi-while this may re¯ect secondary pathology caused by the
dence of marked histopathology in these areas even in theloss of the primary sensory neuronal input, the contradiction
oldest BPAG10/0 animals, ®ndings echoed by previous re-underscores the complexity of the BPAG10/0 situation.
ports on dt/dt mice (Duchen et al., 1963; Sotelo and Guenet,A recent investigation of BPAG1-n mRNA in situ hybrid-
1988). Conversely, we and others (Duchen and Strich, 1964)ization by Bernier and colleagues (1995) described expression
have detected signi®cant pathology in the muscle spindles,in the developing and postnatal DRG and cranial nerve nuclei
leading us to conclude that this may be a more plausibleV, VIII, IX, and X, in agreement with the ®ndings presented
explanation for the dystonic phenotype (see below).here. This study also detected hybridizing grains throughout
the cerebellum and some extrapyramidal motor nuclei, and
the authors predicted that pathology in these areas could help Robust Developmental Expression of BPAG1-n
account for the dystonic phenotype (see Bernier et al., 1995, Despite Normal Embryogenesis in Null Mice
and references therein). In our study, we detected no mRNA
We were surprised to discover that BPAG1-n is expressedin these areas during embryonic and early postnatal develop-
ment; we have, however, observed antibody staining in cere- in the developing nervous system as early as E9.5. In fact,
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sibility of a development defect is the dirth, though clearly
not absence, of myelination in the sensory ®bers at P4. While
we cannot rule out the fact that BPAG1-n may provide some
key axonal-based cue to guide the onset of myelination, it
seems more likely that the inability to properly myelinate
some sensory axons is instead the result of an impediment
in the process caused by precocious axonal swellings.
Our ®ndings of BPAG1-n expression in developing sen-
sory neurons were intriguing in light of the delayed onset
of sensory neuron pathology in BPAG1 null mice. While
there is always the possibility that there is redundancy im-
parted by a second cytoskeletal linker protein with similar
embryonic expression patterns and functions as BPAG1-n,
it seems equally plausible that sensory neurons may have
cytoskeletal requirements that vary with age. Perhaps dur-
ing the time period of axon guidance and target establish-
ment, a ¯uid network of neuro®laments is needed, i.e., one
that is not tightly anchored to the underlying cortical cy-
toskeleton of actin ®laments. We postulate that only after
neurons have established their connections to target cells
would there be a need to tether the neuro®laments to the
actin cytoskeleton. It remains to be established whether
this need is to protect the axon against mechanical stress
or to keep the neuro®laments anchored so that ef®cient
axonal transport can take place. This idea correlates well
with the knowledge of neuro®lament protein expression in
axons, where an ``immature'' network of NF-L and NF-M
is seen during embryogenesis, while a gradually maturing,
potentially more rigid neuro®lament network is seen begin-
FIG. 9. BPAG10/0 sensory neuronal changes occur before appear- ning in late embryogenesis and corresponding to expression
ance of the overt phenotype. Postnatal Day 4 BPAG1 wild-type and
of NF-H (Carden et al., 1987).0/0 mice were processed for ultrastructural analysis. Semithin sec-
tions were stained with Toludine blue. (A) 0/0 dorsal root. Note
the prominent axonal swellings (arrowheads). (B, C)0/0 vs wild-type Distinct Motor Neuron and Spindle Pathology:
dorsal roots. Note the relative lack of myelination in the knockout Their Bearing on the BPAG1 Null Phenotype
section. Bar represents 15 mm in A, 20 mm in B, and 20 mm in C.
Motor neuron degeneration in dt had been thought to be
exclusively secondary, but our results now open the possi-
bility that a primary defect could underlie the limited pa-
thology of these neurons in dt animals. Regardless of thethis expression pattern renders BPAG1-n among the earliest
markers known for developing neurons. Other curious fea- origin of this degeneration, it does not seem to extend to
the main target tissue of motor neurons, extrafusal skeletaltures of BPAG1-n expression were the intense cRNA expres-
sion in the ventral neural tube of the developing embryo muscle ®bers, which appear normal in dt at almost all ages.
In this regard, it is tempting to speculate that BPAG1-nand the dramatic decline of labeling in motor neurons post-
natally. Interestingly, Kothary et al. (1988) found similar plays a role in the gamma motor neurons that innervate the
muscle spindle: this is the only muscle structure that seemsembryonic expression of LacZ in the neural tube and DRGs
in a dt/dt line generated by an accidental 70-kb insertion to exhibit marked abnormalities early in the degenerative
process in our BPAG1-n null mice.of hsp70-LacZ genes accompanied by a 45-kb deletion at
this locus. However, this LacZ mRNA was not detected Based upon the fact that the muscle spindles seem normal
in 4-day-old BPAG1-n null mice, it seems that spindle mor-postnatally and thus does not fully correlate with endoge-
nous BPAG1-n expression. phogenesis per se is not affected by the absence of BPAG1-
n. Rather, the degenerative process appears to be dependentDespite the elaborate BPAG1-n expression patterns that we
observed in the fetus, embryonic morphogenesis does not upon the loss of functional interactions with sensory neu-
rons (and possibly gamma motor neurons), as they begin toappear to depend upon BPAG1-n. Furthermore, while we see
axonal pathology in sensory neurons as early as Postnatal display axonal swellings. Given that the timing of muscle
spindle degeneration seems to correlate with the onset ofDay 4 (P4), normal numbers of dorsal root ganglion neurons
seem to be present, and the spinal cord appears to be appropri- clinical defects, an aberration in spindle function is the
most likely cause of both the ataxic and dystonic move-ately sized. The only observation that might suggest the pos-
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V. M.-Y. (1987). Two-stage expression of neuro®lament polypep-has been posited that the clinical features of human dysto-
tides during rat neurogenesis with early establishment of adultnia may occur as a consequence of improper regulatory sig-
phosphorylation patterns. J. Neurosci. 7, 3489±3504.nals from the muscle spindle, even though the primary pa-
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